Who
Jason Ryan
Director
Company insider
Files Form 4 as: Executive Chairman, GeneDx Holdings; Director, Singular Genomics Systems; Director, SomaLogic; Officer, Dianthus Therapeutics; Chief Financial Officer, Foundation Medicine.
In numbers
- Trades disclosed
- 180
- Buys
- 2
- Sells
- 47
- Bought
- $161K
- Sold
- $19.2M
- Companies
- 5
- Companies where not an officer
- 2
- First trade
- 6 Feb 2014
- Last trade
- 18 Jun 2026
- Last filed
- 23 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Jun 2026filed 23 Jun 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Code M | —3,576 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | WGS GeneDx Holdingsoption or derivative · Providers & Facilities | SEC FORM 4 Code M | —3,576 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | WGS GeneDx Holdingsoption or derivative · Providers & Facilities | SEC FORM 4 Code M | —3,576 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Code M | —3,576 at $0.00 | filing |
| 27 Aug 2025filed 27 Aug 2025 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $1.1M8,818 at $125.07 | filing |
| 27 Aug 2025filed 27 Aug 2025 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $1.1M8,969 at $126.15 | filing |
| 27 Aug 2025filed 27 Aug 2025 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $694K5,443 at $127.44 | filing |
| 27 Aug 2025filed 27 Aug 2025 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $442K3,452 at $128.04 | filing |
| 27 Aug 2025filed 27 Aug 2025 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $1.3M9,890 at $129.59 | filing |
| 27 Aug 2025filed 27 Aug 2025 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $195K1,500 at $130.01 | filing |
| 27 Aug 2025filed 27 Aug 2025 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $149K1,150 at $129.65 | filing |
| 18 Jun 2025filed 23 Jun 2025 | WGS GeneDx Holdingsoption or derivative · Providers & Facilities | SEC FORM 4 Code A | —3,576 at $0.00 | filing |
| 18 Jun 2025filed 23 Jun 2025 | WGS GeneDx Holdingsoption or derivative · Providers & Facilities | SEC FORM 4 Code M | —12,924 at $0.00 | filing |
| 18 Jun 2025filed 23 Jun 2025 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Code M | —12,924 at $0.00 | filing |
| 21 Feb 2025filed 25 Feb 2025 | Singular Genomics Systemsoption or derivative | SEC FORM 4 Code D | —1,333 at $0.00 | filing |
| 21 Feb 2025filed 25 Feb 2025 | Singular Genomics Systemsoption or derivative | SEC FORM 4 Code D | —1,541 at $0.00 | filing |
| 21 Feb 2025filed 25 Feb 2025 | Singular Genomics Systemsoption or derivative | SEC FORM 4 Code D | —2,466 at $0.00 | filing |
| 21 Feb 2025filed 25 Feb 2025 | Singular Genomics Systemsoption or derivative | SEC FORM 4 Code D | $22K2,466 at $8.84 | filing |
| 20 Nov 2024filed 21 Nov 2024 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $640K9,361 at $68.36 | filing |
| 20 Nov 2024filed 21 Nov 2024 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $130K1,857 at $69.84 | filing |
News
No headline names them, or the companies they trade most, lately.